Your browser doesn't support javascript.
loading
Reducing travel-related SARS-CoV-2 transmission with layered mitigation measures: Symptom monitoring, quarantine, and testing
Michael A Johansson; Hannah Wolford; Prabasaj Paul; Pamela S Diaz; Tai-Ho Chen; Clive M Brown; Martin S Cetron; Francisco Alvarado-Ramy.
Affiliation
  • Michael A Johansson; Centers for Disease Control and Prevention
  • Hannah Wolford; Centers for Disease Control and Prevention
  • Prabasaj Paul; Centers for Disease Control and Prevention
  • Pamela S Diaz; Centers for Disease Control and Prevention
  • Tai-Ho Chen; Centers for Disease Control and Prevention
  • Clive M Brown; Centers for Disease Control and Prevention
  • Martin S Cetron; Centers for Disease Control and Prevention
  • Francisco Alvarado-Ramy; Centers for Disease Control and Prevention
Preprint in English | medRxiv | ID: ppmedrxiv-20237412
Journal article
A scientific journal published article is available and is probably based on this preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See journal article
ABSTRACT
Balancing the control of SARS-CoV-2 transmission with the resumption of travel is a global priority. Current recommendations include mitigation measures before, during, and after travel. Pre- and post-travel strategies including symptom monitoring, testing, and quarantine can be combined in multiple ways considering different trade-offs in feasibility, adherence, effectiveness, cost and adverse consequences. Here we use a mathematical model to analyze the expected effectiveness of symptom monitoring, testing, and quarantine under different estimates of the infectious period, test-positivity relative to time of infection, and test sensitivity to reduce the risk of transmission from infected travelers during and after travel. If infection occurs 0-7 days prior to travel, immediate isolation following symptom onset prior to or during travel reduces risk of transmission while traveling by 26-30%. Pre-departure testing can further reduce risk if testing is close to the time of departure. For example, testing on the day of departure can reduce risk while traveling by 37-61%. For transmission risk after travel with infection time up to 7 days prior to arrival at the destination, isolation based on symptom monitoring reduced introduction risk at the destination by 42-56%. A 14-day quarantine after arrival, without symptom monitoring or testing, can reduce risk by 97-100% on its own. However, a shorter quarantine of 7 days combined with symptom monitoring and a test on day 3-4 after arrival is also effective (95-99%) at reducing introduction risk and is less burdensome, which may improve adherence. To reduce the risk of introduction without quarantine, optimal test timing after arrival is close to the time of arrival; with effective quarantine after arrival, testing a few days later optimizes sensitivity to detect those infected immediately before or while traveling. These measures can complement recommendations such as social distancing, using masks, and hand hygiene, to further reduce risk during and after travel.
License
cc0
Full text: Available Collection: Preprints Database: medRxiv Type of study: Experimental_studies / Prognostic study Language: English Year: 2020 Document type: Preprint
Full text: Available Collection: Preprints Database: medRxiv Type of study: Experimental_studies / Prognostic study Language: English Year: 2020 Document type: Preprint
...